LabGenius Therapeutics appoints three experts to its team of scientific advisors

Pioneering therapeutic antibody optimization, LabGenius Therapeutics utilizes advanced technologies to improve drug development and clinical translation.

Generic industry group sues Minnesota, calling price caps ‘unconstitutional’

Generic industry group Association for Accessible Medicines has sued Minnesota Attorney General Keith Ellison in federal court, claiming certain drug pricing provisions in a new

July 7, 2023

Neuroscience has to grapple with a long legacy of racism if it wants to move into the future

Many parts of neuroscience research have a race problem. Black people are often excluded from studies due to the texture of their hair, receive erroneous

November 29, 2023

FDA asks adcomm if AstraZeneca needs another study on Imfinzi before and after lung cancer surgery

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

July 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.